517 related articles for article (PubMed ID: 14972473)
1. Herbal and vitamin supplement use in a prostate cancer screening population.
Barqawi A; Gamito E; O'Donnell C; Crawford ED
Urology; 2004 Feb; 63(2):288-92. PubMed ID: 14972473
[TBL] [Abstract][Full Text] [Related]
2. Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study.
Beebe-Dimmer JL; Wood DP; Gruber SB; Douglas JA; Bonner JD; Mohai C; Zuhlke KA; Shepherd C; Cooney KA
Urology; 2004 Feb; 63(2):282-7. PubMed ID: 14972472
[TBL] [Abstract][Full Text] [Related]
3. The effect of alpha-blocker and 5alpha-reductase inhibitor intake on sexual health in men with lower urinary tract symptoms.
Barqawi AB; Myers JB; O'Donnell C; Crawford ED
BJU Int; 2007 Oct; 100(4):853-7. PubMed ID: 17662074
[TBL] [Abstract][Full Text] [Related]
4. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
Miner M; Rosenberg MT; Perelman MA
Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancer.
Uzzo RG; Brown JG; Horwitz EM; Hanlon A; Mazzoni S; Konski A; Greenberg RE; Pollack A; Kolenko V; Watkins-Bruner D
BJU Int; 2004 May; 93(7):955-60. PubMed ID: 15142142
[TBL] [Abstract][Full Text] [Related]
6. Use of over-the-counter medications and herbal remedies in pregnancy.
Refuerzo JS; Blackwell SC; Sokol RJ; Lajeunesse L; Firchau K; Kruger M; Sorokin Y
Am J Perinatol; 2005 Aug; 22(6):321-4. PubMed ID: 16118721
[TBL] [Abstract][Full Text] [Related]
7. Use of nonprescription medications for perceived cardiovascular health.
Artz MB; Harnack LJ; Duval SJ; Armstrong C; Arnett DK; Luepker RV
Am J Prev Med; 2006 Jan; 30(1):78-81. PubMed ID: 16414428
[TBL] [Abstract][Full Text] [Related]
8. The use of herbal supplements and alternative therapies by patients with amyotrophic lateral sclerosis (ALS).
Vardeny O; Bromberg MB
J Herb Pharmacother; 2005; 5(3):23-31. PubMed ID: 16520295
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater.
Kaplan SA; McConnell JD; Roehrborn CG; Meehan AG; Lee MW; Noble WR; Kusek JW; Nyberg LM;
J Urol; 2006 Jan; 175(1):217-20; discussion 220-1. PubMed ID: 16406915
[TBL] [Abstract][Full Text] [Related]
10. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
Nickel JC; Elhilali M; Vallancien G;
BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
[TBL] [Abstract][Full Text] [Related]
11. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
Roehrborn CG; Kaplan SA; Kraus SR; Wang JT; Bavendam T; Guan Z
Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961
[TBL] [Abstract][Full Text] [Related]
12. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
[TBL] [Abstract][Full Text] [Related]
13. Herb and vitamin supplementation use among a general ophthalmology practice population.
West AL; Fetters MD; Hemmila MR; Gorenflo DW; Kiyota A; Moroi-Fetters S
Am J Ophthalmol; 2005 Mar; 139(3):522-9. PubMed ID: 15767064
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
[TBL] [Abstract][Full Text] [Related]
15. Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).
Rosen RC; Giuliano F; Carson CC
Eur Urol; 2005 Jun; 47(6):824-37. PubMed ID: 15925080
[TBL] [Abstract][Full Text] [Related]
16. Association of lower urinary tract symptoms with sexual dysfunction: a cross-cultural study between Japanese and American men with localized prostate cancer.
Namiki S; Litwin MS; Kwan L; Kagawa-Singer M; Ishidoya S; Saito S; Arai Y
BJU Int; 2009 Oct; 104(8):1071-6. PubMed ID: 19519765
[TBL] [Abstract][Full Text] [Related]
17. [Doxazosin in the gastrointestinal therapeutic system (GITS) and doxazosin standard in patients with benign prostatic hyperplasia. Double-blind trial of efficacy and tolerability].
Gratzke P; Kirby RS
Fortschr Med Orig; 2000 Jul; 118 Suppl 2():83-92. PubMed ID: 15700491
[TBL] [Abstract][Full Text] [Related]
18. Effect of terazosin on prostatism in men with normal and abnormal peak urinary flow rates.
Lepor H; Nieder A; Feser J; O'Connell C; Dixon C
Urology; 1997 Mar; 49(3):476-80. PubMed ID: 9123722
[TBL] [Abstract][Full Text] [Related]
19. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial.
Johnson TM; Jones K; Williford WO; Kutner MH; Issa MM; Lepor H
J Urol; 2003 Jul; 170(1):145-8. PubMed ID: 12796667
[TBL] [Abstract][Full Text] [Related]
20. Consumption of dietary supplements and over-the-counter and prescription medications in men participating in the Prostate Cancer Prevention Trial at an academic center.
Grainger EM; Kim HS; Monk JP; Lemeshow SA; Gong M; Bahnson RR; Clinton SK
Urol Oncol; 2008; 26(2):125-32. PubMed ID: 18312929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]